According to our latest study on “Dermal Fillers Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Material, Application, and End User,” the market is projected to reach US$ 9,421.33 million by 2028 from US$ 4,391.98 million in 2021; it is estimated to grow at a CAGR of 11.5% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the dermal fillers market is primarily attributed to an increase in preference for minimally invasive procedures, growth in population belonging to age group 30–65, and rise in consumer attraction toward beauty and wellness. However, the high cost of surgeries hampers the market growth.
Based on product, the dermal fillers market is segmented into biodegradable and non-biodegradable. In 2021, the biodegradable segment is expected to hold a larger share of the market, and it is expected to register a higher CAGR in the market during the forecast period. Biodegradable fillers include collagens, hyaluronic acids (hyalurons), hydroxylapatite, poly-l-lactic acid (PLLA), and cadaveric tissue.
Get PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPRE00002992/
The dermal fillers market has been segmented on the bases of product, material, application, and end user. Based on product, the market is segmented into biodegradable and non-biodegradable. Based on material, the dermal fillers market has been segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, and other materials. Based on application, the market has been segmented into facial line correction treatment, lip enhancement, facelift, scar treatment, and others. Based on end user, the market has been segmented into dermatology clinics, multispecialty hospitals, ambulatory surgical centers, and others.
In recent years, the adoption of minimally invasive procedures has increased worldwide. A minimally invasive surgery offers patients several benefits such as smaller incisions, faster recovery times, and reduced pain and scarring. Several minimally invasive dermatological techniques have been developed for facial rejuvenation. Injectable dermal fillers are injected into the upper layers of the dermis to treat superficial fine wrinkles or into the deep dermis or subcutaneous space for facial volume augmentation.
Age plays a significant role in defining the specific needs of medical esthetic procedures; adults more often request minimally invasive methods. Moreover, people aged 35–55 years prefer minimally invasive esthetic procedures over surgery. Plastic surgeons are becoming more willing to explore them, and minimally invasive cosmetic and esthetic procedures are now an established interdisciplinary topic.
AbbVie Inc., Galderma, Merz Pharma, Suneva Medical, BIOXIS pharmaceuticals, HUADONG MEDICINE CO.,LTD, BIOPLUS CO., LTD., TEOXANE LABORATORIES, BIOHA LABORATORIES, and Prollenium Medical Technologies are among the leading companies operating in the dermal fillers market.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]